12 Once they identify such factors, testing will be able to tell you if you have these biomarkers
The recently published SURPASS-2 has been conducted in order to compare the efficacy and safety of the three doses of tirzepatide with the GLP-1 agonist semaglutide at an injectable dose of 1 mg in patients with T2DM inadequately controlled with metformin monotherapy
If your BMI (Body Mass Index) is above 30 or its above 27 and you ALSO have an additional health condition like sleep apnea, high cholesterol or high blood pressure, you may qualify for the help of one of these medications
[7] [8] When trial results are split by sex, women often lose a greater percentage of body weight than men at the same dose, which is part of why lower dosing is a rational conversation for midlife women rather than a trend
Talk to Your Provider About Dosing If side effects feel too strong, a provider may: keep you at a lower dose longer delay the next dose increase in some cases, reduce the dose Never change your dose on your own